News | March 15, 2019
Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. DermTech markets and...
Subcutaneous sarcoidosis (also known as ‘Darier-Roussy sarcoidosis’) is a rare subcutaneous form of sarcoidosis, occurring in 1.4 to six percent of patients with sarcoidosis. It is characterized by firm, asymptomatic to slightly...
News | March 21, 2019
Results for the primary endpoint of Biofrontera AG's Phase 3 clinical trial evaluating the safety and efficacy of conventional photodynamic therapy (PDT) with Ameluz and the BF-RhodoLED lamp for the treatment of actinic keratoses (AK)...
Biofrontera Reports Positive Phase 3 Results with Ameluz for PDT of AKs on Extremities and Trunk/Neck
Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc.
Gabrielle Kartzmark, BS; Victoria R. Negrete, MD; and John Pujals, MD
This is dedicated to our friends in pharma…and you know who you are.
Neal Bhatia, MD, FAAD
Complaints and concerns abound, but remedies are slow in coming.
New research offers additional evidence that mitotic rate may have a role in clinical decision-making.
Jonathan Wolfe, MD
What do we know about the effects of these commonly used and important molecules?
Sophia Akhiyat, MD; and Edit B. Olasz Harken, MD, PhD
New Guidelines Offer SRT Treatment Recommendations for Skin Cancers, Keloids
Study Shows 97% Cure Rate for Superficial Radiation Therapy for BCC and SCC